Contact us : info@bioworlde.com
Home > Product > Primary Antibodies
FGFR2 (V501) polyclonal antibody BS1124
  • Western blot (WB) analysis of FGFR2 pAb at 1:500 dilution Lane1:HepG2 whole cell lysate(40ug) Lane2:U-87MG whole cell lysate(40ug) Lane3:Myla2059 whole cell lysate(40ug) Lane4:HCT116 whole cell lysate (40ug)
  • Immunohistochemistry (IHC) analyzes of FGFR2 (V501) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Product NameFGFR2 (V501) polyclonal antibody
Catalog No.BS1124
Swiss-ProtP21802
Host Rabbit
ReactivityHuman
ApplicationsWB IHC
Application_allWB: 1:500~1000 IHC: 1:50~1:200
BiowMW~ 120,95,86 kDa
Alternative NameFibroblast growth factor receptor 2; FGFR-2; K-sam; KGFR; Keratinocyte growth factor receptor; CD332; FGFR2; BEK; KGFR; KSAM
Purification&PurityThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
ConjugateUnconjugated
ModificationUnmodification
Browse similar products>>
Size Price
50ul $158
100ul $275
Add to cart My orders
Product Name :
FGFR2 (V501) polyclonal antibody
Background :
Acidic and basic fibroblast growth factors (FGFs) are members of a family of multifunctional polypeptide growth factors that stimulate proliferation of cells of mesenchymal, epithelial and neuroectodermal origin. Like other growth factors, FGFs act by binding and activating specific cell surface receptors.These include the Flg receptor or FGFR-1, the Bek receptor (or FGFR-2), FGFR-3, FGFR- 4, FGFR-5 and FGFR-6. These receptors usually contain an extracellular ligandbinding region containing three immunoglobulin-like domains, a transmembrane domain and a cytoplasmic tyrosine kinase domain. The gene encoding human Bek (also esignated K-sam) maps to chromosome 10q26 and is alternatively spliced to produce several isoforms. Heterogeneous mutations in Bek are associated with a range of craniosynostosis syndromes including Pfeiffer syndrome, Crouzon syndrome, Jackson-Weiss syndrome and Apert syndrome.
Product :
Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
FGFR2 (V501) polyclonal antibody detects endogenous levels of FGFR2 protein.
Immunogen :
Synthetic peptide, corresponding to amino acids 480-530 of Human FGFR2.
Conjugate :
Unconjugated
Modification :
Unmodification
  • Western blot (WB) analysis of FGFR2 pAb at 1:500 dilution Lane1:HepG2 whole cell lysate(40ug) Lane2:U-87MG whole cell lysate(40ug) Lane3:Myla2059 whole cell lysate(40ug) Lane4:HCT116 whole cell lysate (40ug)
  • Immunohistochemistry (IHC) analyzes of FGFR2 (V501) pAb in paraffin-embedded human breast carcinoma tissue at 1:100.
Bioworld Biotech only provide peptides for our antibodies and do not provide additional peptide customization services.

Price/Size :

USD 368/1mg/vial



Tips: 

For phospho antibody, we provide phospho peptide(0.5mg) and non-phospho peptide(0.5mg).

Describe :

Blocking peptides are peptides that bind specifically to the target antibody and block antibody binding. These peptide usually contains the epitope recognized by the antibody. Antibodies bound to the blocking peptide no longer bind to the epitope on the target protein. This mechanism is useful when non-specific binding is an issue, for example, in Western blotting (WB) and Immunohistochemistry (IHC). By comparing the staining from the blocked antibody versus the antibody alone, one can see which staining is specific; Specific binding will be absent from the western blot or IHC performed with the neutralized antibody.

Formula:

Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 10 mg/ml.The purity is >90%,tested by HPLC and MS.

Storage:

The freeze-dried powder is more stable. For short time at 2-8°C. For long term storage store at -20°C. 


Note :

This product is for research use only (RUO only). Not for use in diagnostic or therapeutic procedures.
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER